OR WAIT null SECS
February 17, 2023
cGMP line will fill vials, syringes, and cartridges, while supporting small-scale commercial production.
February 14, 2023
South Korea facility expected to provide fill-finish capabilities.
New California plant expected to streamline medicine production.
February 13, 2023
Investment expected to establish additional cGMPs, expand CDMO services.
February 10, 2023
Joint venture expected to address pharma’s injectable drug-filling sector.
February 09, 2023
Collaboration to support biotech company’s clinical and commercial production efforts.
February 08, 2023
Plant is expected to offer packaging, serialization, and third-party contract manufacturing services.
February 07, 2023
Saint-Beauzire complex dedicated to sterile liquid drug production.
The new $43M plasmid manufacturing facility will support both clinical and commercial production in the cancer and infectious disease spaces.
February 06, 2023
CDMO is commissioning third GMP biologics facility in Fremont.